Cleared Traditional

K942769 - BIOINTEGRATOR, BIOINTEGRATOR PLUS

K942769 is an FDA 510(k) clearance for BIOINTEGRATOR, manufactured by Bio Research Institute. The device is a Class 2 Neurology device with product code HCC cleared through the Traditional 510(k) pathway after a 445-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1995
Decision
445d
Days
Class 2
Risk

K942769 is an FDA 510(k) clearance for the BIOINTEGRATOR, BIOINTEGRATOR PLUS. Classified as Device, Biofeedback (product code HCC), Class II - Special Controls.

Submitted by Bio Research Institute (Costati, US). The FDA issued a Cleared decision on September 1, 1995 after a review of 445 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5050 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Neurology submissions.

FDA 510(k) Submission Details - K942769

510(k) Number K942769 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 13, 1994
Decision Date September 01, 1995
Days to Decision 445 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
296d slower than avg
Panel avg: 149d · This submission: 445d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

HCC Device Classification - Class 2, Special Controls

Product Code HCC Device, Biofeedback
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - HCC Device, Biofeedback

All 172
Devices cleared under the same product code (HCC) and FDA review panel - the closest regulatory comparables to K942769.
RELAXPLUS
K951213 · Ultramind International , Ltd. · Sep 1995
A620 EEG
K944615 · Stoelting Co. · Sep 1995
THE BAGNOLI-2 EMG SYSTEM
K945286 · Delsys, Inc. · Sep 1995
J & J I-330 SERIES PHYSIOLOGICAL MONITORING & BIOFEEDBACK INSTUMENT AND USE SOFTWARE APPLICATIONS
K945826 · Medical Device Inspection Co., Inc. · Aug 1995
MUSCLESENSE ELECTROMYOGRAPHY DEVICE
K951350 · Smith and Nephew Donjoy, Inc. · Jun 1995
VERSATELL
K941959 · Progressive Concepts, Inc. · Jun 1995